Medications

Britain to offer all infants meningitis B vaccine

Britain says it will become the first country to offer all babies a vaccine for potentially fatal meningitis B after it reached a price deal with GlaxoSmithKline PLC.

Medications

British drugmaker cutting hundreds of US jobs

Hundreds of British drugmaker GlaxoSmithKline's 17,000 U.S.-based employees will lose their jobs by the end of next year under the pharmaceutical industry's latest restructuring.

Neuroscience

Obama's BRAIN initiative gets more than $300 million

President Barack Obama's initiative to study the brain and improve treatment of conditions like Alzheimer's and autism was given a boost Tuesday with the announcement of more than $300 million in funds.

Inflammatory disorders

ERS: Mepolizumab is glucocorticoid-sparing in asthma

(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published online Sept. ...

Diseases, Conditions, Syndromes

'Realistic' to expect Ebola vaccine by 2015: WHO (Update)

Clinical trials of vaccines for the deadly Ebola virus should soon get underway and will likely be ready for widespread use by early next year, the World Health Organization said Saturday.

page 2 from 18